Early buyers will receive 10% customization on reports.
By application, the in-house application segment is expected to dominate the market in 2017
On the basis of applications, the surface disinfectants market is segmented into in-house, instrument disinfection, and other applications. The in-house application segment accounted for the largest share of the market. The growth of this market segment is mainly driven by the need to reduce the rising incidence of HAIs.
By end user, the hospitals segment is expected to hold the largest share of the market in 2017
In the end user, the surface disinfectants market is segmented into hospitals, clinical laboratories, pharmaceutical companies, and other end users. The hospitals segment holds the largest share in the market. The growth is primarily attributed to the rising incidence of HAIs and growth in the number of hospitals in emerging countries.
Asia to offer lucrative growth opportunities
By region, the global surface disinfectants market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing awareness about infection control in the region are some major factors driving the high growth of this regional segment.
Some of the major players operating in the surface disinfectants market are 3M Company (U.S.), Cantel Medical Corporation (U.S.), Johnson & Johnson (U.S.), Procter & Gamble (U.S.), Reckitt Benckiser Group plc. (U.K.), The Clorox Company (U.S.), Sealed Air Corporation (U.S.). Steris Corporation (U.S.), and Ecolab (U.S.).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
